Cargando…

Access to Coronavirus Disease 2019 Literature

Detalles Bibliográficos
Autor principal:	Hunt, Summer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	New York, Elsevier 2020
Materias:	Editorial & Updates
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529361/ http://dx.doi.org/10.1016/S1751-4851(20)30112-4

Ejemplares similares

Coronavirus Disease 2019 and Stroke
por: Dries, David J., et al.
Publicado: (2021)

Coronavirus Disease 2019: Women and Children
por: Dries, David J.
Publicado: (2021)

Updated Geriatric Cardiology Guidelines of the Brazilian Society of Cardiology - 2019
por: Feitosa-Filho, Gilson Soares, et al.
Publicado: (2019)

Updated Cardiovascular Prevention Guideline of the Brazilian Society of Cardiology - 2019
por: Précoma, Dalton Bertolim, et al.
Publicado: (2019)

Coronavirus Disease 2019: From Exposure to the Intensive Care Unit—Part 1
por: Dries, David J.
Publicado: (2021)

Coronavirus Disease 2019: From Intensive Care Unit to the Long Haul—Part 2
por: Dries, David J.
Publicado: (2021)

The Brazilian Society of Cardiology and Brazilian Society of Exercise and Sports Medicine Updated Guidelines for Sports and Exercise Cardiology - 2019
por: Ghorayeb, Nabil, et al.
Publicado: (2019)

Biocatalytic Parallel Interconnected Dynamic Asymmetric Disproportionation of α‐Substituted Aldehydes: Atom‐Efficient Access to Enantiopure (S)‐Profens and Profenols
por: Tassano, Erika, et al.
Publicado: (2018)

Respiratory infections in Coronavirus disease 2019
por: del Pozo, Jose L.
Publicado: (2022)

Management strategies for dermatomyositis during the coronavirus disease 2019 outbreak
por: Pi, Zixin, et al.
Publicado: (2020)

Healthful Lifestyle May Reduce Alzheimer Disease Risk
por: Hellwig, Jennifer P.
Publicado: (2020)

Changing gears: Medical gloves in the era of coronavirus disease 2019 pandemic
por: Anedda, Jasmine, et al.
Publicado: (2020)

Immunosuppressive and immunomodulatory therapies in dermatology and coronavirus disease 2019 (COVID-19)
por: Mansouri, Parvin, et al.
Publicado: (2021)

Access in all areas? A round up of developments in market access and health technology assessment: part 1
por: Gilardino, Ramiro, et al.
Publicado: (2023)

Towards a multi-arm multi-stage platform trial of disease modifying approaches in Parkinson’s disease
por: Foltynie, Tom, et al.
Publicado: (2023)

Coronavirus Disease 2019 and Stroke
por: Kim, Jong S.
Publicado: (2020)

Challenges of coronavirus disease 2019
por: The Lancet Infectious Diseases
Publicado: (2020)

Universal eye health: increasing access for the poorest
por: Ellison, Elmien Wolvaardt
Publicado: (2013)

Monitoring clinical progression with mitochondrial disease biomarkers
por: Steele, Hannah E, et al.
Publicado: (2017)

Management of laser treatments during the coronavirus disease 2019 pandemic: The Italian experience
por: Bennardo, Luigi, et al.
Publicado: (2021)

ACQUIRED PES CAVUS IN CHARCOT-MARIE-TOOTH DISEASE
por: Maranho, Daniel Augusto, et al.
Publicado: (2015)

Current status of diabetic kidney disease and latest trends in management
por: Kim, Min Kyung, et al.
Publicado: (2022)

Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases
por: Betts, Matthew J, et al.
Publicado: (2019)

Recent updates in factors associated with incidence and screening of diabetic eye disease
por: Sone, Hirohito
Publicado: (2023)

The human DEPhOsphorylation Database DEPOD: 2019 update
por: Damle, Nikhil P, et al.
Publicado: (2019)

Detection of inflammatory bowel disease: diagnostic performance of cross-sectional imaging modalities
por: Horsthuis, Karin, et al.
Publicado: (2007)

Detecting new neurodegenerative disease genes: does phenotype accuracy limit the horizon?
por: Samuels, David C., et al.
Publicado: (2009)

Shockwave treatment for musculoskeletal diseases and bone consolidation: qualitative analysis of the literature()
por: Kertzman, Paulo, et al.
Publicado: (2015)

A new era of diabetic kidney disease treatment with sodium–glucose cotransporter‐2 inhibitors
por: Kume, Shinji, et al.
Publicado: (2022)

AZTEC—azithromycin therapy for prevention of chronic lung disease of prematurity: a statistical analysis plan for clinical outcomes
por: Lau, Tin Man Mandy, et al.
Publicado: (2022)

Statistical analysis plan for the motor neuron disease systematic multi-arm adaptive randomised trial (MND-SMART)
por: Parker, Richard A., et al.
Publicado: (2023)

Feasibility of coronavirus disease 2019 eradication
por: Zheng, Ya-Li, et al.
Publicado: (2020)

Effectiveness of the Shenzhuo formula in the treatment of patients with macroalbuminuria secondary to diabetic kidney disease: protocol update and statistical analysis plan
por: Wei, Yu, et al.
Publicado: (2022)

Arterial Thrombosis and Coronavirus Disease 2019
por: McBane, Robert D.
Publicado: (2021)

Engel in the Time of Coronavirus Disease 2019
por: Davidson, John H.
Publicado: (2021)

Coronavirus Disease 2019 (COVID-19)
por: Goldust, Mohamad
Publicado: (2022)

Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: statistical analysis plan for a randomised controlled trial (UPGRADE trial)
por: Haal, Sylke, et al.
Publicado: (2020)

Serial prophylactic exchange blood transfusion in pregnant women with sickle cell disease (TAPS-2): statistical and qualitative analysis plan for a randomised controlled feasibility trial
por: Seed, Paul T., et al.
Publicado: (2023)

Statistical analysis plan for the randomized controlled trial CardioCare MV investigating a novel integrated care concept (NICC) for patients suffering from chronic cardiovascular disease
por: Ziegler, Andreas, et al.
Publicado: (2020)

Update on the collaborative interventions for circulation and depression (COINCIDE) trial: changes to planned methodology of a cluster randomized controlled trial of collaborative care for depression in people with diabetes and/or coronary heart disease
por: Coventry, Peter A, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_tod72mpvkh7knlfcvkuh9ljc61